Cleveland Clinic
Cleveland Clinic
9500 Euclid Ave.
Cleveland, OH 44195
USA
Gene H. Barnett, M.D.
Robert Weil. M.D.
Research Categories:
-Genetic investigation of malignant and benign gliomas
-Etiology and pathogenesis of metastatic brain tumors
-Stem cells and stem tumor cells
-Benign brain tumors including meningioma, pituitary adenoma, and neurocutaneous disorders
-Clinical research:clinical trials, clinical outcomes, and epidemiology
-Translational research including brain tumor modeling and convection-enhanced delivery
-Immunotherapy
-Clinical outcomes of stereotactic radiosurgery and stereotactic spinal radiosurgery
Research Interest/Projects:
tumor growth; computer-aided brain navigation and interrogation; immunotherapy
-Dr. Lilyana Angelov: Clinical trials; CNS lymphoma; cranial and spinal radiosurgery outcomes
-Dr. Samuel Chao: Clinical trials, radiosurgery outcomes; pathogenesis of radiation necrosis
-Dr. Bruce Cohen: pediatric brain tumors and neurocutaneous disorders; mitochondrial diseases
-Dr. James Finke: immunotherapy of brain tumors
-Dr. Candece Gladson: basic biology of brain tumorigenesis, invasion and migration; angiogenesis
-Dr. Jaharal Haque: Role of STAT and interleukin signaling in gliomagenesis and invasion; role of glioma tumor stem
cells in tumor formation and regulation by JAK-STAT and MYC pathways
-Dr. David Peereboom: clinical trials, including Phase I-Phase III trials
-Dr. Greg Plautz: immunotherapy of glioma tumor stem cells
-Dr. Richard Prayson: Clinical and translational pathology of primary and metastatic brain tumors, benign and malignant
-Dr. Jeremy Rich: Basic and applied science glioblastoma tumor stem cells, including treatment sensitivity and
radiobiological effects
-Dr. Glen Stevens: Neuro-oncology clincal research and outcomes
-Dr. John Suh: Clinical trials, radiosurgery outcomes
-Dr. Tanya Tekautz: Pediatric tumor clinical tirals and tumor outcomes; analysis of BRAF alterations and tumor treatment
outcomes
-Dr. Michael Vogelbaum: Clinical trials; translational research, including translational research including brain tumor
modeling and convection-enhanced delivery
-Robert Weil: genomic and proteomic analysis of primary and metastatic brain tumors; role of CTCF and homologues on
gliomagenesis; microarray and SNP analysis of malignant brain tumors; clinical and outcomes research, including quality
analysis; development of models of tumor formation, including mathematical modeling; identification of brain tumor and
pituitary tumor stem cells; Phase O trials
Support SNO in its mission to advance neuro-oncology research and education. Give today!
Platinum Members:

Gold Members: